awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36946766-063CA9AC-D035-4AF3-93CD-E742830E3E17
Q36946766-063CA9AC-D035-4AF3-93CD-E742830E3E17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36946766-063CA9AC-D035-4AF3-93CD-E742830E3E17
Development of farnesyltransferase inhibitors for clinical cancer therapy: focus on hematologic malignancies.
P2860
Q36946766-063CA9AC-D035-4AF3-93CD-E742830E3E17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36946766-063CA9AC-D035-4AF3-93CD-E742830E3E17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23e01565ba30f5f79e62d0d03d468af6423ed027
P2860
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.